About this trial
Implementation of an evidence-based and best practices acute RRT pathway aiming to decrease acute RRT program and healthcare systems costs while improving important patient-reported outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
none
Trial population
All patients from 15 adult and 3 pediatric Alberta ICUs who receive acute RRT as part of their usual clinical care during the intervention period
Trial design
Other
Prospective
Treatments tested in this trial
KPI reports
Other interventionQuarterly
Prescriber reports
Other interventionIndividualized prescriber reports for acute RRT initiation patterns along with targeted education to ensure that align with best evidence-based practices
Treatment groups
Trial outcomes
Primary outcomes
Key performance indicators (KPI)
Changes in acute KPIs
Health system costs
Acute RRT and healthcare systems costs
Secondary outcomes
Length of renal replacement therapy
Length of time patient receives RRT during their ICU stay
ICU and hospital lengths of stay
Number of days patient spends in the ICU and hospital
ICU and 90 day mortality
number of patients who die before ICU discharge or within 90 days of ICU stay
Rates of RRT dependence at 90 days
number of patients who are receiving RRT at 90 days after ICU stay
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Alberta
Lead sponsor
Alberta Innovates Health Solutions
Collaborator